Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CLONDIAG Chip Technologies was a German biotechnology company specializing in the development of microarray-based diagnostic systems and lab-on-a-chip technologies. Founded in 1998 as a spin-off from the Institute for Physical High Technology in Jena, the company focused on miniaturized testing platforms for clinical diagnostics, environmental analysis, and food safety. Their core products included the ArrayTube and ArrayStrip systems, which enabled multiplexed detection of nucleic acids and proteins in a portable format. The company was acquired by Inverness Medical Innovations (later Alere) in 2006, and its technology served as the foundation for several point-of-care diagnostic platforms, including the Alere i (now Abbott ID NOW). Today, the former CLONDIAG operations continue as part of Abbott's rapid diagnostics division in Jena.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CLONDIAG Chip Technologies.